Dr. Tanya M. Laidlaw completed her medical degree at the University of Massachusetts Medical School, her residency in pediatrics at Massachusetts General Hospital, and then entered an Allergy/Immunology fellowship at the Brigham and Women’s Hospital in Boston, Massachusetts.
She performed her research training in the laboratory of Joshua A. Boyce, MD, where she focused on the pathogenesis of asthma and Aspirin-Exacerbated Respiratory Disease (AERD), and the pro-inflammatory role of the platelet and specific lipids in this disorder. Dr. Laidlaw joined the faculty in 2009, and is now an Associate Professor of Medicine at Harvard Medical School, and is the Director of Translational Research in Allergy and Director of the AERD Center at the Brigham and Women’s Hospital.
Her research continues to be focused on understanding AERD, nasal polyposis, and aspirin and NSAID allergies, and she is dedicated to investigating the causative mechanisms and exploring new treatments for these diseases. Her group at the Brigham and Women’s Hospital’s AERD Center follows over 1400 patients with AERD and nasal polyps and has several ongoing research studies that are recruiting and enrolling patients.